Login
$HAO
$1.62 +$0.02 (1.25%) Pre-market

Ownership

13F as of Q2 2026 · 640.0K shares outstanding

Who owns HAO?

By type of holder
Institutions 0.0% Insiders 0.0% Everyone else 100.0%
Institutional ownership
0.0%
-3.1 pts vs last qtr
Institutional holders
0
-2 vs last qtr
Net shares bought
−19.6K
by institutions in Q2 2026
New / sold out
0 / 2
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • XTX Topco Ltd SOLD OUT −19.2K
  • UBS Group AG SOLD OUT −459

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Haoxi Health Technology Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2026
−99.9%
−82.27% a year
Each share's claim on the business
+101196.6%
grew without buying or selling a share
Spent on buybacks vs paid in stock
— vs $58.6K
over 5 fiscal years
Diluted shares, split-adjusted
46412.6M25.3M2022: 25.0M shares'222023: 1.1M shares'232024: 478 shares'242025: 936 shares'252026: 24.7K shares'26
Buybacks Stock-based comp
$0$29.3K$58.6K2022 buybacks: $02022 stock comp: $0'222023 buybacks: $02023 stock comp: $0'232024 buybacks: $02024 stock comp: $0'242025 buybacks: $02025 stock comp: $58.6K'252026 buybacks: $02026 stock comp: $0'26

How patient are the owners?

No 13F manager reports holding HAO.

Super Investors

Investment managers reporting HAO on Form 13F
XT
XTX Topco Ltd
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
UG
UBS Group AG
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

Institutional Funds

Mutual funds and ETFs reporting HAO on Form N-PORT; together they hold 0.0% of the company
No fund reports holding HAO yet.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support